Why Biohaven (BHVN) Is Up 25.0% And What's Next After FDA Review Acceptance

Ono Pharmaceutical Co., Ltd. (OPHLY) Stock Price, News, Quote & History

Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights

Biohaven partners with Ono in $100m IgG degrader deal

Biohaven Enters Strategic Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions, Lead Candidate BHV-1300 in Phase 3 for Graves' Disease

Biohaven licenses IgG degrader portfolio to Japan’s Ono (BHVN:NYSE)

Are Investors Undervaluing Ono Pharmaceutical Co. (OPHLF) Right Now?

Ono Pharmaceutical Co. (OPHLF) Q1 Earnings and Revenues Top Estimates

Bioventus (BVS) to Report Q2 Results: Wall Street Expects Earnings Growth

Earnings Preview: Ono Pharmaceutical Co. (OPHLF) Q1 Earnings Expected to Decline

Strength Seen in Ono Pharmaceutical Co. (OPHLF): Can Its 9.2% Jump Turn into More Strength?

Should Value Investors Buy Ono Pharmaceutical Co. (OPHLF) Stock?

Ono Pharmaceutical Co. (OPHLF) Moves 10.4% Higher: Will This Strength Last?

Ono Pharmaceutical . Stock Price Forecast. Should You Buy OPHLY?